Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/2003
06/26/2003US20030118594 Stable formulations of mhc-peptide complexes
06/26/2003US20030118593 Antigen binding fragments, designated 4B5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
06/26/2003US20030118592 Binding domain-immunoglobulin fusion proteins
06/26/2003US20030118589 Growth factor binding molecules
06/26/2003US20030118584 Administration of antibody combining site-containing molecules that specifically bind to specific class of reversibly-bound GPIIb/IIIa fibrinogen receptor antagonist compounds
06/26/2003US20030118582 Pharmaceutical composition comprising factor VII polypeptides and protein C inhibitors
06/26/2003US20030118580 Useful for treating bleeding episodes
06/26/2003US20030118579 Sparc-related proteins
06/26/2003US20030118578 Contacting a cell expressing an IKK- beta gene with a candidate compound; and measuring IKK- beta gene expression or IKK-beta protein activity in the cell
06/26/2003US20030118577 Use of analogues of superoxide dismutase for treating hepatocellular insufficiencies
06/26/2003US20030118574 Useful for treating bleeding episodes due to trauma, surgery, lowered count or activity of platelets
06/26/2003US20030118573 MB-1 analogs and uses thereof
06/26/2003US20030118570 Vectors for tissue-specific replication
06/26/2003US20030118564 Intra-tumoral administration of il-12 encoding nucleic acid molecules
06/26/2003US20030118561 Antisense modulation of phospholipid scramblase 4 expression
06/26/2003US20030118557 Axon repair
06/26/2003US20030118553 Vector constructs for gene-therapy mediated radionuclide therapy of undifferentiated and medullary thyroid carcinomas and non-thyroidal tumours and metastases mediated thereof
06/26/2003US20030118549 Removal, contacting with interferon, reinsertion
06/26/2003US20030118548 Aqueous solution containing glycerin buffer; controlling pH; freeze drying; mutiple sclerosis therapy
06/26/2003US20030118546 Genetic engineering; polypeptides; antitumor agent
06/26/2003US20030118536 Topical compositions and methods for treatment of adverse effects of ionizing radiation
06/26/2003US20030118528 Topical delivery of codrugs
06/26/2003US20030118525 Administering carnosine
06/26/2003US20030118517 Topical oral dosage forms containing bismuth compounds
06/26/2003US20030118513 Lung administering; bioavailability
06/26/2003US20030118510 Immobilization of insulin; antidiabetic agents
06/26/2003US20030118509 Novel methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators
06/26/2003US20030118507 Methods of using 46828, a human acyl-CoA synthetase
06/26/2003CA2746308A1 Method for treating human papilloma virus
06/26/2003CA2473890A1 Methods and pharmaceutical compositions for gnrh-i and gnrh-ii modulation of t-cell activity, adhesion, migration and extravasation
06/26/2003CA2471777A1 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control
06/26/2003CA2470811A1 Protease inhibitors of the coagulation cascade isolated from dysidea sponges
06/26/2003CA2470763A1 Novel pharmaceutical composition of interferon gamma or pirfenidone with molecular diagnostics for the improved treatment of interstitial lung diseases
06/26/2003CA2470640A1 Use of hmgb proteins and nucleic acids that code therefor
06/26/2003CA2470590A1 Pharmaceutical composition comprising an oil/water/oil double microemulsion incorporated into a solid support
06/26/2003CA2470419A1 Growth factor modified protein matrices for tissue engineering
06/26/2003CA2469984A1 Process for the purification and/or isolation of biologically active granulocyte colony stimulating factor
06/26/2003CA2469812A1 Mutants of human insulin-like growth factor binding protein-3 (igfbp-3) and uses thereof
06/26/2003CA2468880A1 Tetrahydrocarbazole derivatives as ligands for g-protein coupled receptors (gpcr)
06/26/2003CA2468790A1 Chemokine mutants acting as chemokine antagonists
06/26/2003CA2468690A1 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use
06/26/2003CA2467732A1 Novel human proteins, polynucleotides encoding them and methods of using the same
06/26/2003CA2465888A1 Topical compositions and methods for treatment of adverse effects of ionizing radiation
06/26/2003CA2453417A1 Nanoparticle delivery vehicle
06/26/2003CA2446292A1 Nucleic acid-associated proteins
06/25/2003EP1321526A2 Adenovirus-mediated gene transfer to cardiac and vascular smooth muscle
06/25/2003EP1321522A1 Promoting cell survival by inhibiting BARD1 apoptotic activity
06/25/2003EP1321521A1 Ribozymes directed against flt-1
06/25/2003EP1321519A1 Polypeptide having L-asparaginase activity
06/25/2003EP1321516A2 Hydrogel matrix for cellular tissue storage
06/25/2003EP1321476A2 Binding protein
06/25/2003EP1321475A1 Gene useful for diagnosis and treatment of aplasia of corpus callosum and aspermatogensis and use thereof
06/25/2003EP1321153A1 Remedies for interstitial pneumonia, method of constructing animal model of this disease and screening method with the use of the same
06/25/2003EP1321152A1 Antidote for org 31540/SR 90107A
06/25/2003EP1321151A1 Antiparkinsonism drugs
06/25/2003EP1320621A2 Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol, nef and modifications
06/25/2003EP1320614A2 Novel proteases
06/25/2003EP1320613A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
06/25/2003EP1320609A2 Isolated peptides which bind to hla-c molecules and uses thereof
06/25/2003EP1320605A2 Isolated nucleic acid molecules which encode a soluble il-tif/il-22 receptor or binding protein which binds to il-tif/il-22 and uses thereof
06/25/2003EP1320604A2 Cripto mutant and uses thereof
06/25/2003EP1320603A1 Uses of the gjb6 gene for treating certain types of alopecia including the clouston's syndrome, and for screening compounds capable of being efficient in the treatment of alopecia with genetic susceptibility
06/25/2003EP1320602A2 Spas-1 cancer antigen
06/25/2003EP1320601A1 Human and rat pgc-3, ppar-gamma coactivations and splice variants thereof
06/25/2003EP1320600A1 Transporters and ion channels
06/25/2003EP1320598A2 Polypeptides and corresponding molecules for disease detection and treatment
06/25/2003EP1320591A2 Atcr-1, a human acyltransferase and uses thereof
06/25/2003EP1320589A2 Antiangiogenic polypeptides and methods for inhibiting angiogenesis
06/25/2003EP1320585A2 Oxidoreductases
06/25/2003EP1320584A2 Transferases
06/25/2003EP1320582A2 Adenovirus e1b-55k single amino acid mutants and methods of use
06/25/2003EP1320551A1 The identification and development of specific monoclonal antibodies to squamous cell carcinoma
06/25/2003EP1320550A2 G-protein coupled receptors
06/25/2003EP1320549A2 Pumpcn compositions and uses thereof
06/25/2003EP1320548A2 Transporters and ion channels
06/25/2003EP1320547A1 Transfer factor from birds eggs
06/25/2003EP1320545A2 Recombinant endothelial cell growth inhibitors derived from a mammalian plasminogen
06/25/2003EP1320541A2 Tgf-beta inhibitors and methods
06/25/2003EP1320540A2 Peptidomimetic protease inhibitors
06/25/2003EP1320387A2 Pharmaceutical compositions for sustained drug delivery
06/25/2003EP1320386A1 A novel cationic lipopolymer as biocompatible gene delivery agent
06/25/2003EP1320384A1 The synergetic effects of hgf and antibacterial treatment
06/25/2003EP1320382A2 Novel methods for inhibition of viral infection
06/25/2003EP1320378A2 Improved protocol for paracentesis
06/25/2003EP1320377A1 Hla binding peptides and their uses
06/25/2003EP1320376A2 Treatment of prostate cancer
06/25/2003EP1320359A2 Thermogelling biodegradable aqueous polymer solution
06/25/2003EP1320358A2 Topical formulations for delivery of interleukin-11
06/25/2003EP1320295A1 Collagen/polysaccharide bilayer matrix
06/25/2003EP1261365A4 Product and method for biological anchoring of connective tissue to bone
06/25/2003EP1233985A4 Collagen
06/25/2003EP1140019B1 Aerosol formulations for buccal and pulmonary application
06/25/2003EP1071704B1 Novel matrix metalloproteinase inhibitors and down-regulators
06/25/2003EP1025125B1 Aggregates of human insulin derivatives
06/25/2003EP1019428B1 Inverted chimeric and hybrid oligonucleotides
06/25/2003EP0980205B1 Use of a combination of tall-104 cells with adriamycin or cisplatin in the therapy of malignancies
06/25/2003EP0971703B1 Use of microparticles having a protein and an antibody adsorbed thereon for preparing a pharmaceutical composition for intranasal administration
06/25/2003EP0966282B1 Use of the angiotensin ii antagonists losartan and exp-3174 to treat symptomatic heart failure
06/25/2003EP0932411B1 Compositions containing immunogenic molecules and granulocyte-macrophage colony stimulating factor, as an adjuvant
06/25/2003EP0906434B1 Mch4 AND Mch5, APOPTOTIC PROTEASE, NUCLEIC ACIDS ENCODING AND METHODS OF USE
1 ... 1822 1823 1824 1825 1826 1827 1828 1829 1830 1831 1832 1833 1834 1835 1836 1837 1838 1839 1840 1841 1842 ... 3163